About 15% of Triple-Negative-Breast-Cancer (TNBC) present silencing of the BRCA1 promoter methylation and are assumed to be Homologous Recombination Deficient (HRD). The gene discussed is BRCA1; the disease is hyperinsulinemic hypoglycemia, familial, 4.